US Big Pharma firm Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion as the ...

The situation on the ground remains unchanged, ONGC sources said, despite the energy major deploying its 'most experienced' ...